Levinson Mitchell E.'s Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Oct 11, 2022
- Accession no.
- 0001387131-22-010379
- Filed
- Oct 11, 2022
- Trade date
- Oct 7, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $69.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levinson Mitchell E.CIK 0001674465 | Director, Officer (Chief Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2022 | Common Stock | PPurchaseAcquired | +8,770 | $2.29 | +$20,083.3 | 46,274 | Direct | |
| Oct 7, 2022 | Common Stock | PPurchaseAcquired | +8,810 | $2.27 | +$19,998.7 | 12,945 | Indirect | |
| Oct 7, 2022 | Common Stock | PPurchaseAcquired | +4,400 | $2.26 | +$9,944 | 5,134 | Indirect | |
| Oct 7, 2022 | Common Stock | PPurchaseAcquired | +4,500 | $2.23 | +$10,035 | 5,234 | Indirect | |
| Oct 7, 2022 | Common Stock | PPurchaseAcquired | +4,300 | $2.29 | +$9,847 | 5,034 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.